PA (MDR-non-XDR and XDR) colonization as the explanatory variable of 175
interest. In the crude analysis, variables associated with exposure were 176
candidates for multivariate analysis with if p < 0.20. Data were analyzed using 177 included in the study are illustrated in Table 1 . 191
The prevalence of PA colonization at ICU admission was 27% (112/414 192 patients): 89 (22%) for non-MDR PA, 6 (1%) for MDR-non-XDR PA and 17 (4%) 193 for XDR PA. In addition, the prevalence of ICU-acquired PA colonization was 194 22% (67/302 patients): 43 (14%) for non-MDR, 11 (4%) for MDR-non-XDR, and 195 13 (4%) for XDR. Finally, among the PA colonized patients, 36 new carrier 196 episodes were observed in 34 patients (8%) during their ICU stay ( Figure 1) . 197
Thus, the total number of PA episodes was 215; 132 non-MDR and 83 MDR (37
Microbiological and genotypic analysis. Among the 37 MDR-non-200
XDR isolates analyzed, 13 were polyclonal, 19 had identical genotypes to 201 previously described isolates (17), and were identified as ST111 clone; the 202 remaining 5 had clonal relatedness by PFGE suggesting the occurrence of 203 another cluster. In addition, XDR PA isolates were comparable with those of the 204 predominant endemic clone in our hospital (5) and belonged to ST175. Identical 205 susceptibility patterns were observed in all XDR PA strains; only amikacin and 206 colistin retained activity in the XDR phenotype. 207 PFGE analysis of 18 pairs of non-MDR isolated from the same patients, 208
were clonally identical in 10 pairs (56%) of subsequent MDR-non-XDR strains. 209
The remaining 8 pairs (44%) were unrelated to the non-MDR PA strain by 210 PFGE; additionally, all these 8 MDR-non-XDR strains showed clonal 211 relatedness. In the remaining pairs, 5 non-MDR and subsequent XDR had 212 isolates with PFGE patterns that were unrelated to prior PA isolates, but similar 213 to those obtained from other patients (Table 2) . These data confirmed clonal 214 dissemination of both MDR-non-XDR and XDR-PA isolates in the ICU (5,17). 215
The dynamics of intestinal PA colonization. The unadjusted 216 probabilities of PA carriage were analyzed among the 302 non-carriers 217 identified at ICU admission. The mean of ICU stay for 235 non-colonized 218 patients was 10.8±9.2 days versus 15.6±10.5 days for 67 colonized patients 219 (p=0.001). Of these colonized patients, we identified 97 episodes: 67 initial 220 episodes of ICU-acquired colonization and 30 subsequent new carrier episodes 221 (Figure 1 ). At 10 days after ICU admission, the probabilities of PA carriage were 222 44%, 24%, and 24% for non-MDR, MDR-non-XDR, and XDR-PA respectively 223 (log Rank, p = 0.02; Figure 2 (Table 4) . 251
252

DISCUSSION 253
In this study, we undertook active surveillance of intestinal PA colonization in 254 ICU patients over an 18-month period. Overall, 936 samples rectal swab were 255 obtained from 414 patients, of which 8% were newly colonized by different PA 256
phenotypes. There were significant differences in patient age, prior 257 hospitalization and acute illness severity, but not prior antibiotic use, between 258 colonized and non-colonized patients at ICU admission. Research into the 259 molecular epidemiology revealed that XDR PA phenotypes had identical 260 genotypes, whereas 65% of MDR non-XDR isolates presented two concomitant 261
clusters. Furthermore, MLST study showed that the two major MDR clusters 262 belonged to the ST 175 and ST 111 high-risk clones (5,17). 263
We conducted an extensive evaluation of how drug resistance levels 264 differed at the time of intestinal colonization. We found differences in 265 colonization dynamics, with intestinal colonization occurring more prematurely 266 for non-MDR PA isolates. Consequently, strains exhibiting high resistance 267 levels to antimicrobials have delayed intestinal colonization due to the time 268 required for selective pressure to facilitate the emergence of new resistant 269 mutants or for preexisting subpopulations of resistant organisms to emerge. In 270 fact, molecular analysis of paired non-MDR and MDR-non-XDR PA isolates, 271
showed that genetically identical isolates occurred in about 56% of the strains 272 studied, due to the development of resistance in patients exposed to antibiotics. In addition, the observation that similar PA genotypes colonized several 277 ICU patients strongly suggests cross-colonization. The presumed route of 278 colonization in MDR-non-XDR and XDR epidemic strains of PA could initially be 279 exogenous, and may occur more early than intestinal colonization. 280
Unfortunately, the only surveillance samples in this study were by rectal swab; 281 no other patient or environmental cultures were performed. Thus, rectal cultures 282 may not be adequate to quantify the initial colonization of patients with clonal 283 strains, despite epidemiological findings suggesting that patients provide a 284 reservoir for further environmental contamination and cross-transmission (5) 285 Interestingly, 13% of the patients were not colonized during prolonged 286 ICU stays despite high antimicrobial selection pressures. It is possible that our 287 detection methods for PA were insufficiently sensitive, allowing cases of rectal 288 colonization to be missed. However, it is equally plausible that some unknown 289 non-antimicrobial-related host factors may have increased the level of 290 colonization resistance in some patients (18). 291
We studied antimicrobial use and the extent of exposure before study 292 inclusion. It is important to know the duration of exposure to understand the 293 relationship between antibiotic resistance and microorganism. The present 294 study provides data concerning the impact of the duration of antimicrobial use 295 on their ability to promote digestive tract colonization with MDR PA (2,3). After 296 multivariate analysis, the only agents that remained significantly associated with 297 the MDR-PA isolation were the fluoroquinolones, and the carbapenems (both 298 ertapenem and group 2 carbapenems). analyses. Other studies have examined the effect of introducing ertapenem into 320 a hospital on the susceptibility of PA to group 2 carbapenems (27,28); in these 321 studies, the authors suspect that the improved susceptibility of PA to group 2 322 carbapenems was related to decreased fluoroquinolone use. However, in lineassociation of ertapenem with the appearance of PA resistance patterns (9) . 325
This could be explained through collateral damage on the indigenous 326 microflora, with its high capacity to kill significant numbers of normal 327 gastrointestinal flora, promoting an ecological pressure for the spread of MDR 328 PA; another possibility is that substantial and prolonged ertapenem use in the 329 past could selectively promote the development of resistance mechanisms in 330
PA. 331
We found a trend toward reduced risks of clonal MDR-non-XDR PA 332 versus polyclonal MDR-non-XDR intestinal PA colonization with piperaillin-333 tazobactam. These data suggests that piperacillin-tazobactam was more 334 selection neutral that other agents, and may result in the selection of fewer 335 resistant PA strains. 336
There were several limitations in our study. The data set on which we 337 
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